Cointime

  • Haberler
  • Haber
  • Para Birimi
  • Köşe Yazısı
  • Etkinlik
  • Bitcoin $90,493.52 -0.67%
  • Ethereum $3,081.19 -0.99%
  • BNB $900.55 +0.87%
  • Optimism $0.31 -0.82%
  • Arbitrum $0.21 -1.35%
  • Solana $135.88 -2.67%
  • Polygon $0.22 +2.77%
  • Cosmos $2.55 +5.25%
  • Avalanche $13.66 -1.65%
  • Bitcoin $90,493.52 -0.67%
  • Ethereum $3,081.19 -0.99%
  • BNB $900.55 +0.87%
  • Optimism $0.31 -0.82%
  • Arbitrum $0.21 -1.35%
  • Solana $135.88 -2.67%
  • Polygon $0.22 +2.77%
  • Cosmos $2.55 +5.25%
  • Avalanche $13.66 -1.65%
Home / Karyopharm Therapeutics / investors

Karyopharm Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
5
14
Karyopharm Therapeutics is funded by 14 investors. Avidity Partners and Foresite Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Avidity Partners Yes Post-IPO Equity
Foresite Capital Yes Series B
Chione Yes Series A
Multiple Myeloma Research Foundation Yes Grant
Adage Capital Management - Post-IPO Equity
Armistice Capital - Post-IPO Equity
HealthCor Partners - Post-IPO Equity
Heights Capital Management - Post-IPO Equity
Marshall Wace - Post-IPO Equity
Rubric Capital Management - Post-IPO Equity
SilverArc Capital - Post-IPO Equity
Surveyor Capital - Post-IPO Equity
Delphi Ventures - Series B
New Leaf Venture Partners - Series B

Contact

Newton,Massachusetts,United States
+1 617 658 0600
Cointime
İçerikler
  • Haberler
  • Girişimler
  • Araştırmalar
  • Teknoloji
  • Etkinlik
Şirket.
  • Hakkımızda
  • Reklam İşbirliği
  • Sorumluluk Reddi
  • © 2023 Cointime. Tüm Hakları Saklıdır
  • Gizlilik Politikası
  • Hizmet Şartları